Healthcare >> CEO Interviews >> December 18, 2000
TAFFY J. WILLIAMS is President and Chief Executive Officer of IMCOR
Pharmaceutical Co. (formerly Photogen Technologies Inc.). Dr. Williams
was President of InKine Pharmaceutical Company (formerly Panax
Pharmaceutical Company). Prior to that, he was President, CEO and
Chairman of Panax Pharmaceutical Company. In addition to executive
management skills, the ability to grow companies and new business
development experience, Dr. Williams is the author of eight patents, one
invention registration, nine patent applications and 53 published
articles. He also has been the recipient of several prestigious awards,
including a postdoctoral fellowship from the National Institutes of
Health, 'Most Significant Scientific Publication' awards from the Naval
Medical Research Institute in 1985 and 1986, and the Civil Service
Special Achievement Award for restructuring research activities in 1986.
Dr. Williams holds a Bachelor's degree in Chemistry from the University
of Notre Dame, a PhD in Biochemistry from the University of South
Carolina, and he did postdoctoral training at the University of South
Carolina and the University of Michigan. Profile
Photogen?
Dr. Williams: Photogen is focused on cancer therapy and diagnosis. We
are developing technology in three areas:
